drug Archives - Page 15 of 67 - World Asthma Foundation

January 27, 2015

GSK Expands Portfolio of Asthma/COPD Medicines in U.S. – Drug Discovery & Development

GSK Expands Portfolio of Asthma/COPD Medicines in U.S.
Drug Discovery & Development
GlaxoSmithKline plc announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in …
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPDRTT News
New Inhalers for Asthma, COPD LaunchedMonthly Prescribing Reference
GSK expands its portfolio of medicines in the US for patients with asthma and …SYS-CON Media (press release)

all 5 news articles »

View full post on asthma – Google News

January 24, 2015

Monitor improved drug adherence in children with asthma – Healio

Monitor improved drug adherence in children with asthma
Healio
“Use of an electronic monitoring device with an in-built audiovisual reminder significantly improved adherence in school-aged children with asthma, with corresponding improvements in several indicators of asthma control, although we did not note any …

View full post on asthma – Google News

January 22, 2015

Jefferson Scientists Find Clues to Safer Asthma Drug – NBC 10 Philadelphia

Jefferson Scientists Find Clues to Safer Asthma Drug
NBC 10 Philadelphia
Researchers at Thomas Jefferson University in Philadelphia have identified a promising new drug target that points the way to a second generation of asthma treatments. Beta-agonists are highly effective for asthmatics: they turn on receptors to relax …

View full post on asthma – Google News

January 14, 2015

Asthma Drug Shows Promise in Treatment of Obesity and Diabetes – Genetic Engineering & Biotechnology News

Asthma Drug Shows Promise in Treatment of Obesity and Diabetes
Genetic Engineering & Biotechnology News
University of Michigan scientists have revealed the underlying mechanisms on how an asthma drug currently in clinical trials for the treatment of obesity and other related metabolic disorders increases sugar metabolism by generating a novel signal …

and more »

View full post on asthma – Google News

December 11, 2014

BRIEF-Vectura’s asthma drug meets main goal in mid-stage trial – Reuters

BRIEF-Vectura's asthma drug meets main goal in mid-stage trial
Reuters
Dec 11 (Reuters) – Vectura Group Plc. * Positive phase IIb/III results for VR475 in asthma. * Investigational drug/device combination VR475 met primary endpoint and has shown significant clinical benefit in a phase IIb/III trial in severe asthma patients.

View full post on asthma – Google News

November 29, 2014

FDA reviewing Boehringer drug use for asthma treatment – The Ridgefield Press

FDA reviewing Boehringer drug use for asthma treatment
The Ridgefield Press
Under the new application it is being evaluated as a long-term, once-daily, add-on maintenance treatment of asthma in patients 12 years of age and older who remain symptomatic on at least inhaled corticosteroids, and it is not currently approved for …

View full post on asthma – Google News

November 28, 2014

Asthma Treatment Market (Drug) Worth $23 Billion by 2023 – PR Newswire (press release)

Asthma Treatment Market (Drug) Worth $23 Billion by 2023
PR Newswire (press release)
ReportsnReports.com adds PharmaPoint: Asthma – Global Drug Forecast and Market Analysis to 2023 research report that says asthma treatment market value will grow across eight major countries (the US, UK, France, Germany, Spain, Italy, Japan, and …

and more »

View full post on asthma – Google News

November 15, 2014

New Imaging Method Could Improve Asthma Treatment – Drug Discovery & Development

Drug Discovery & Development

New Imaging Method Could Improve Asthma Treatment
Drug Discovery & Development
A team of researchers, led by the Universities of Cambridge and Birmingham, have used a laser beam trap to examine how drug particles from asthma inhalers behave as they are projected through the air. Their findings could improve the effectiveness of …

and more »

View full post on asthma – Google News

November 11, 2014

Dual-action Sanofi asthma drug performs well in test – Allentown Morning Call

Dual-action Sanofi asthma drug performs well in test
Allentown Morning Call
Nov 11 (Reuters) – An experimental biotech drug for severe asthma from France's Sanofi, which has a location in Swiftwater, Monroe County, and its U.S. partner Regeneron has produced good results in clinical tests, suggesting its dual-action mechanism …

View full post on asthma – Google News

November 11, 2014

Sanofi/Regeneron asthma drug successful in Phase 2 trial – Seeking Alpha (registration)

Sanofi/Regeneron asthma drug successful in Phase 2 trial
Seeking Alpha (registration)
The three highest doses of dupilumab in combination with standard-of-care therapy met the primary endpoint of a statistically significant improvement from baseline in forced expiratory volume over one second (FEV1) at week 12 in patients with high …

View full post on asthma – Google News